Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Bauer

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
Duration of anticoagulation: applying the guidelines and beyondKenneth A Bauer
The New England Journal of Medicine|June 23, 2015
Targeted Anti-AnticoagulantsKenneth A Bauer
Hematology. American Society of Hematology. Education Program|November 25, 2006
New anticoagulantsKenneth A Bauer
Best Practice & Research. Clinical Haematology|June 3, 2004
Fondaparinux: a new synthetic and selective inhibitor of Factor XaKenneth A Bauer
Seminars in Thrombosis and Hemostasis|June 20, 2002
Selective inhibition of coagulation factors: advances in antithrombotic therapyKenneth A Bauer
British Journal of Haematology|October 6, 2004
Low intensity warfarin: is it clinically useful in venous thromboembolism management?Kenneth A Bauer
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Hormone replacement therapy and the factor V Leiden mutationKenneth A Bauer
Seminars in Thrombosis and Hemostasis|January 5, 2005
Role of thrombophilia in deciding on the duration of anticoagulationKenneth A Bauer
Blood|July 15, 2017
The challenge of hospital-related thrombosisKenneth A Bauer
Reviews in Neurological Diseases|April 23, 2010
New oral anticoagulants in development: potential for improved safety profilesKenneth A Bauer
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Hematology. American Society of Hematology. Education Program|January 18, 2011
Duration of anticoagulation: applying the guidelines and beyondKenneth A Bauer
The New England Journal of Medicine|June 23, 2015
Targeted Anti-AnticoagulantsKenneth A Bauer
Hematology. American Society of Hematology. Education Program|November 25, 2006
New anticoagulantsKenneth A Bauer
Best Practice & Research. Clinical Haematology|June 3, 2004
Fondaparinux: a new synthetic and selective inhibitor of Factor XaKenneth A Bauer
Seminars in Thrombosis and Hemostasis|June 20, 2002
Selective inhibition of coagulation factors: advances in antithrombotic therapyKenneth A Bauer
British Journal of Haematology|October 6, 2004
Low intensity warfarin: is it clinically useful in venous thromboembolism management?Kenneth A Bauer
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Hormone replacement therapy and the factor V Leiden mutationKenneth A Bauer
Seminars in Thrombosis and Hemostasis|January 5, 2005
Role of thrombophilia in deciding on the duration of anticoagulationKenneth A Bauer
Blood|July 15, 2017
The challenge of hospital-related thrombosisKenneth A Bauer
Reviews in Neurological Diseases|April 23, 2010
New oral anticoagulants in development: potential for improved safety profilesKenneth A Bauer
Pageof 10